Peptron said Friday it has applied for a patent on a week-lasting injection of Saxenda, a daily injection for obesity treatment manufactured by Novo Nordisk.Despite its hasty process of daily injections, Saxenda rapidly became popular because it was not a psychotropic drug and it showed excellent ef
A typhoid conjugate vaccine (TCV), jointly developed by the International Vaccine Institute and SK Bioscience, has met its primary endpoint in phase 3 clinical trials in Nepal, the IVI said on Thursday.The primary endpoint was to compare immune non-inferiority with Typbar-TCV, the current WHO-prequa
Huons Global said it would spin off its bio business and establish it as a separate subsidiary called Huons Biopharma by next April.Huons Biopharma will be capitalized at 2 billion won ($1.8 million), and the company will promote the group's bio business, such as botulinum toxin, and develop new dru
The U.S. International Trade Commission has upheld the preliminary decision that Daewoong Pharmaceutical copied Medytox's manufacturing process of its botulinum toxin product.ITC ordered a 21-month ban on the export of Daewoong Pharmaceutical's BTX products, Nabota, to the U.S.However, the final rul
“Vedolizumab showed a faster efficacy than conventional TNF-α blockers in the first-line biological treatment of ulcerative colitis (UC). The agent was particularly potent and safe in healing the intestinal mucosa, which is crucial for prognosis. Vedolizumab demonstrated the strongest effect in the
Genexine’s process to develop the Covid-19 vaccine is being delayed, as the company recently changed its Covid-19 vaccine candidate material and received approval for the new plan from the Ministry of Food and Drug Safety.According to company officials on Friday, Genexine has changed the substance f
Bristol-Myers Squibb (BMS) Korea designated Dec. 16 as "Patient Caregiver Day" as part of the company’s efforts to expand its social contribution activities by improving support and awareness for patients’ caregivers."BMS Korea is struggling to create a healthy society for all as patient caregivers
“Dupixent (ingredient: dupilumab) inhibits the Th2 pathway, which is involved in the Covid-19 cytokine storm. But it does not affect the Th1 pathway required to fight the infection. A majority of atopic dermatitis (AD) patients who were using Dupixent were asymptomatic or had mild symptoms even when
As global pharmaceutical companies have won regulatory approval for Covid-19 vaccines, they are joining the hands of one another to develop conjugate vaccines to enhance their treatments’ efficacy, industry sources said on Tuesday.For instance, AstraZeneca recently said that it plans to start clinic
Korean pharmaceutical companies speed up clinical trials to develop Covid-19 treatments using drug repositioning, in keeping with the government’s schedule to introduce Covid-19 therapies by Jan 2021.For instance, Daewoong Pharmaceutical and Chong Kun Dang are testing pancreatic drugs Foistar (ingre
Korea’s recent nod for more hospitals to use GC Pharma’s experimental Covid-19 plasma therapy is boosting anticipation for the commercialization of plasma treatment.GC Pharma’s investigational drug GC5131 targets severely ill Covid-19 patients instead of other types of plasma therapies that aim to t
Genexine said it has decided to acquire a 16.64 percent equity stake of gene-editing firm Toolgen to become its largest shareholder.Genexing took over the share through the stock exchange with Toolgen’s major shareholders, including Dr. Kim Jin-soo. Kim will continue to help Toolzen develop and comm
Hanmi Pharmaceutical said Friday that it has confirmed excellent efficacy, including complete remission, of its new drug candidate HM43239 for treating acute myelogenous leukemia (AML).The company presented some cases of patients who participated in phase 1 and 2 joint clinical trials conducted by D
Prosecutors have made an additional indictment of Medytox CEO Jung Hyun-ho for allegedly manipulating documents related to the botulinum toxin product, "Innotox."According to industry sources on Thursday, the Cheongju District Public Prosecutors' Office in North Chungcheong Province pressed charges
Daewoong Pharmaceutical said it has confirmed the efficacy of its “Foistar” tablets in improving the inflammation in Covid-19 patients.Researchers compared the clinical efficacy and safety by comparing seven patients that took Foistar tablets (camostat mesylate) with 22 patients who took Kaletra tab
Amgen Korea will create the best environment to treat osteoporosis patients who are at a very high risk of fracture with Evenity, which recently began to receive insurance benefits, the company said Thursday."The annual treatment cost for osteoporotic fracture exceeds that of breast cancer, myocardi
GC Pharma’s Covid-19 plasma therapy, GC5131A, is raising expectations for a treatment option for severe patients after a man in his 70s fully recovered after undergoing the treatment.This patient was not included in the clinical trial. Still, the healthcare provider used the drug on him after receiv
Xeljanz XR (extended-release), a rheumatoid arthritis treatment by Pfizer, has obtained regulatory approval in Korea.As the oral tablet can be taken once daily, instead of twice a day, it will improve patient convenience and compliance, the company said.The Ministry of Food and Drug Safety recently
Local pharmaceutical companies are teaming up with biotech firms to utilize cutting-edge technologies such as liquid biopsy and deep learning to discover candidates for innovative medicines.Boryung Pharmaceutical has been most active in joining hands with the biotech industry.On Tuesday, the company
After AstraZeneca and Oxford University published the results of the phase-3 trial on Covid-19 vaccine candidate AZD1222, regulatory institutions worldwide have begun approval review.However, the investigational vaccine data did not provide a clear direction for dosing, making it uncertain whether t